Malaria Prevention Program
Malaria Prevention
CommercialActive
Key Facts
About Sixty Degrees Pharmaceuticals
Sixty Degrees Pharmaceuticals is a U.S.-based biotech targeting major global infectious diseases like malaria, dengue, and COVID-19. The company appears to be advancing a portfolio of small-molecule therapeutics, with a recent commercial launch indicated for malaria prevention. Its strategy involves both product development and commercialization to serve travelers and endemic regions, positioning itself at a critical intersection of public health need and market opportunity.
View full company profileTherapeutic Areas
Other Malaria Prevention Drugs
| Drug | Company | Phase |
|---|---|---|
| srRNA Vaccine for Malaria | Replicate Bioscience | Pre-clinical |
| Malaria Vaccine | VLP Therapeutics | Pre-clinical |
| Matrix-M in R21 Vaccine | Novavax | Marketed |